|
FAM105B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16859999998997E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.12999999996233E-06 |
| Normal-vs-Stage2 |
2.20139999562718E-08 |
| Normal-vs-Stage3 |
3.93619999999872E-05 |
| Normal-vs-Stage4 |
1.813870E-04 |
| Stage1-vs-Stage2 |
8.738200E-03 |
| Stage1-vs-Stage3 |
8.755400E-01 |
| Stage1-vs-Stage4 |
9.076200E-01 |
| Stage2-vs-Stage3 |
2.039600E-02 |
| Stage2-vs-Stage4 |
7.057600E-02 |
| Stage3-vs-Stage4 |
8.491200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.5999999959997E-08 |
| Normal-vs-AfricanAmerican |
1.860690E-03 |
| Normal-vs-Asian |
1.222600E-04 |
| Caucasian-vs-AfricanAmerican |
6.861200E-01 |
| Caucasian-vs-Asian |
9.285000E-01 |
| AfricanAmerican-vs-Asian |
6.493200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11480000009045E-07 |
| Normal-vs-Female |
2.0898000000491E-06 |
| Male-vs-Female |
5.092800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.96259999999793E-05 |
| Normal-vs-Age(41-60Yrs) |
3.51539999998707E-07 |
| Normal-vs-Age(61-80Yrs) |
4.15429999955919E-07 |
| Normal-vs-Age(81-100Yrs) |
2.675200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.039900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.108400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.749000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.234200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.287030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.681400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.705000E-01 |
| Classical-VS-Follicular |
7.81890000522978E-08 |
| Classical-VS-Other |
1.076390E-01 |
| Classical-VS-Normal |
9.63600000000175E-05 |
| Tall-VS-Follicular |
1.283890E-02 |
| Tall-VS-Other |
2.324600E-01 |
| Tall-VS-Normal |
1.452370E-02 |
| Follicular-VS-Other |
9.060400E-01 |
| Follicular-VS-Normal |
2.50790055389416E-10 |
| Other-VS-Normal |
6.076200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.91530000140483E-08 |
| Normal-vs-N1 |
3.85820000000647E-05 |
| N0-vs-N1 |
3.724000E-01 |
|
|
